logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

BCa: neratinib-induced diarrhea common but short-lived in ExteNET

Grade 3/4 diarrhea affects 40% of patients and lasts 5 days.